Literature DB >> 3530756

Relationship between the cysteine-proteinase-inhibitory function of rat T kininogen and the release of immunoreactive kinin upon trypsin treatment.

T Moreau, N Gutman, A el Moujahed, F Esnard, F Gauthier.   

Abstract

The potential kininogenic function of rat T kininogen has been studied in parallel with the cysteine-proteinase-inhibitory function also carried by this molecule. Proteolytic cleavage of the molecule was observed upon incubation with catalytic amounts of trypsin. These conditions do not permit any significant release of immunoreactive kinin and do not modify the total papain-inhibiting capacity of T kininogen. As trypsin concentration increases in the reaction mixture, immunoreactive kinin is liberated and the total papain-inhibiting capacity decreases accordingly, as indicated by titration studies. This decrease, however, does not exceed 50% of the initial value even at a trypsin concentration as high as 75 microM, indicating that only one of the two inhibitory sites has been inactivated. The remaining inhibitory fragment corresponds to a peptide of apparent Mr 24 000, which binds papain at least as well as native T kininogen. T kininogen, therefore, appears as a potent proteinase inhibitor and/or a proteinase inhibitor precursor, whereas its kininogenic function remains questionable since no specific kininogenase able to release T kinin or another kinin under physiologically compatible conditions has been found so far.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530756     DOI: 10.1111/j.1432-1033.1986.tb09873.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  2 in total

1.  Purification and characterization of a new cystatin inhibitor from Taiwan cobra (Naja naja atra) venom.

Authors:  M Brillard-Bourdet; V Nguyên; M Ferrer-di Martino; F Gauthier; T Moreau
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

2.  The myostimulating effect of tissue kallikrein on rat uterus.

Authors:  J Damas; V Bourdon; J C Pinto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.